Newcastle University Featured PhD Programmes
Ludwig-Maximilians-Universität Munich Featured PhD Programmes
Bournemouth University Featured PhD Programmes
Heriot-Watt University Featured PhD Programmes
Monash University Featured PhD Programmes
"immunotherapy"×
10 miles

immunotherapy PhD Projects, Programs & Scholarships

We have 23 immunotherapy PhD Projects, Programs & Scholarships

  • "immunotherapy" ×
  • clear all
Order by 
Showing 1 to 10 of 23
  MRC DiMeN Doctoral Training Partnership: Rationally Designed Oncolytic Reovirus-Based Immunotherapy for Hepatocellular Carcinoma
  Dr A Samson, Prof A Whitehouse, Dr C McKimmie
Application Deadline: 21 January 2019
Background. The incidence of hepatocellular carcinoma (HCC) in the UK has increased more than four-fold since 1990, and worldwide HCC is the second biggest cause of cancer-specific mortality.
  How an IFNγ target gene mediates resistance to immunotherapy
  Dr A Hurlstone, Prof K Williams, Dr J Bruce
Applications accepted all year round
Metastatic melanoma, a highly aggressive form of skin cancer, can respond well to immunotherapy with immune checkpoint inhibitors, but there are still a significant proportion of patients not benefitting or for whom benefits are not durable.
  A pilot study of oral immunotherapy as a treatment to desensitise horses with insect bite hypersensitivity to Culicoides spp
  Dr AD Wilson
Applications accepted all year round
The project. Equine Insect Bite Hypersensitivity (IBH) is a Type I IgE-mediated allergy of horses to salivary proteins of Culicoides spp.
  Defining the role of p53 in cancer immunotherapy
  Prof Y. Haupt, Dr S. Haupt, Dr P. Neeson
Applications accepted all year round
Despite clear evidence of an association between the tumour suppressor p53 and immunity, a gap in knowledge exists regarding its role in modulating immune responses, or its value in predicting patient responses to immunotherapy.
  Machine Learning and Integrative Approaches in Immunology: Developing machine-learning and mathematical models to understand heterogeneity of response to personalised cancer immunotherapy
  Dr H Koohy, Prof V Cerundolo, Prof T Dong, Prof A Simmons
Application Deadline: 26 July 2019
Cancer immunology is an area of cancer research that is gaining tremendous momentum. However, responses to immunotherapy are heterogeneous and patient care could be substantially improved by better understanding of how and why responses to immunotherapeutic approaches vary in different patients.
  T Cell Biology: Studying how lymphocytes decide to mount immune responses against, for example, tumours (cancer immunotherapy).
  Prof S Davis
Application Deadline: 26 July 2019
Studying how lymphocytes decide to mount immune responses against, for example, tumours (cancer immunotherapy).
  Examining the Potential of C-type Lectin-like Receptors (CLRs) as Immunotherapy Targets
  Research Group: Centre for Experimental Medicine
  Dr S Orr
Application Deadline: 20 January 2019
Invasive fungal infections kill more people per year than TB or malaria. Immunosuppressed patients (cancer patients undergoing chemotherapy, acute myeloid leukaemia, HIV, bone marrow transplant patients) are at high risk of developing invasive fungal infections.
  PhD in Infection & Immunity - Modifying human cytomegaloviruses to drive expansion of effector natural killer and cytotoxic T cells
  Dr E Wang, Dr R Stanton
Application Deadline: 27 February 2019
Natural Killer (NK) cells and CD8+ cytotoxic T lymphocytes (CTL) are immune cells known to kill cancerous and virus-infected cells and are being used to treat forms of these diseases.
  PhD studentship in oncolytic virotherapy and cancer immunology: Establishing a potent immuno-oncolytic virotherapy for colorectal cancer.
  Dr A Parker, Prof A Gallimore, Dr A Godkin
Application Deadline: 1 February 2019
An exciting, fully funded PhD studentship opportunity. working at the interface between oncolytic virotherapy and cancer immunotherapy to develop a refined, tumour targeted “immunovirotherapy” suitable for colorectal cancer treatment.
  Using T cells to eradicate cancer
  Prof T. Tiganis
Applications accepted all year round
The Tiganis Laboratory is seeking a highly enthusiastic student to conduct research in immuno-oncology and the development of novel immunotherapeutic approaches for the treatment of cancer.
Show 10 15 30 per page


FindAPhD. Copyright 2005-2019
All rights reserved.